Dr. Bethune brought recognition and change to Canada through his advancements and dedication in medicine. Specifically, during the Spanish Civil War in 1936, he organized a mobile blood bank to be setup on the front lines of the war. Soon after, Bethune and his team were completing over 1000 blood transfusions a day. “His mobile blood bank is considered the greatest medical innovation from the war.” (macleans.ca). In essence, the mobile blood bank revolutionized medicine and brought recognition to Canada by providing a more immediate and accessible help to the wounded.
Stoichiometry is a section of chemistry that involves using the relationships between reactants or products in a chemical reaction to determine the desired quantitive data. 4. Using the balanced chemical reaction between Sodium carbonate and Calcium Carbonate given in page 92 of your lab manual (first paragraph of procedure), find the mass of Sodium Carbonate (in grams) needed in reaction? Na2CO3(aq)+CaCl22H20(aq)-CaCO3(s)+2NaCl(aq)+2H2O Date:_____3/30/2015____________ Name______Chloe Flake______________ 1. Title: 1pt Stoichiometry Of A Precipitation Reaction 2.
Use a new glucose strip and record Data: Conclusion: According to my data, pH levels do, in fact, affect the results of Lactex. I say this because in my experiment, pre-enzyme, my solutions were all negative except for the soda. I used the test strips to determine if they were negative or positive solutions. After I put in the enzyme, Lactex, my results changed. Vinegar, Antacid, and Soap all became positive solutions after I put in the enzyme.
The pharmaceutical industry is a domain of great innovations, which unfortunately has witnessed many an innovative drug faltering due to sheer laxity of marketers who fail to communicate the critical differentiating features and the related benefits to the right customers. Added to this is the complacency which sets in with the initial success of the product. The study presented herein looked into the various market related aspects of the pharmaceutical industry and the importance of innovation in the same. Also, it investigated the reasons for the waning of Merck KGaA’s innovative drug-Glucovance in the US market. It provides ample evidence for the possible reasons aforesaid for the failure of innovative products.
UV0787 GREEN OX Overview In the fall of 2003, the new products division of Palmer Jackson, Inc., a Cincinnati-based food and beverage manufacturer, successfully perfected a technique for dissolving common antioxidants such as Vitamin E and Selenium into high-glucose beverages. The result was a new line of sports beverages with the added benefit of antioxidants. While the medical community was far from unanimous in their opinion of the benefits of antioxidants, some reputable studies linked the use of these vitamins and minerals to a reduced risk of certain types of cancers. Natural food stores, health food stores, drug stores, and even conventional grocery retailers often carried antioxidant pills. Palmer Jackson hired AccuityBrand, a brand consultancy specializing in developing product names and logos, to name and develop creative packaging for this new product.
I added a few drops of 3% Hydrogen Peroxide and it resulted in bubble formation. The positive gram stain and positive catalase test indicated that the organism belonged to the Staphylococcus Genus, which meant it was now time to pinpoint the species based on differential and selective biochemical tests. To ensure that my genus identification was correct I performed a Bile Esculin Slant with a fish tail streak on my unknown bacteria. This test resulted in neither growth nor a black precipitate; therefore I could conclude that my unknown was not Streptococci or Enterococci but indeed Staphylococcus. Next I observed the isolation streak on my Blood Agar Plate and found pinpoint, round, entire and flat colony morphology as well as an alpha hemolytic reaction pattern, indicating red blood cell ion leakage which is characteristic of S. epidermidis.
Reasons & Advantages The existing structure was increasing competition between Roche and Genentech as the product of the two companies were coming in direct competition with each other in multiple markets especially in US The existing ownership and operating model gave Roche little opportunities to address the increasing the overlap and duplication between these two firms (for example R&D work) The product licensing agreement between Roche and Genentech was set to expire in 2015. With the expiry of this agreement Roche will lose the right to develop and commercialize products of Roche which were major source of revenue for Roche After the expiry of the licensing agreement of product licensing agreement between Roche and Genentech a new arm’s length agreement would have to be negotiated where the product pipeline could be sold to the highest bidder Due to existing shareholding structure, in order to protect the rights of minority shareholders, Roche could not get access to intellectual property of Genentech High growth of biotechnology sector Not much innovation in Pharma sector which was leading to acquisition by larger companies leading to consolidation of industry Acquisition of Genentech will help Roche generate cost synergies of 60% of $750-850 Million by cutting costs and streamlining Genentech had large chunk of Cash ($ 9.5 Billion) which Roche could not access to ownership structure. The acquisition will provide a Roche access to this cash. Risks Possibility of Genentech’s scientists leaving the company due to the fear of loss of independence and entrepreneurial spirit of Genentech after acquisition by Roche Threat of potential intellectual property going out
• Weaknesses: Lacking hardware and software manufacture. • Opportunities: To add quality to low cost production offered. Compaq was the market leader in fault-tolerant computing and industry standard servers • Threats: Struggling with the organic growth. Board wants a merger to achieve greater market share. Need more research and development funding.
When you are a company that has a vision to bring a new product or piece of technology on the scene, it can be a challenging experience. Even if your product takes off in the market, it takes good planning, direction and an excellent team to keep the company’s image and product on track with the demands of the market. While a company may have the potential to make a great deal of money with their innovative product, if they’re not careful, they can end up bankrupt, like Kodak, the inventor of the camera. Even though they created a product that revolutionized the world of photography, they were not able to keep up with the times, whereas one of their competitors, Fujifilm, rose to the challenge. The Kodak Company began in 1878 when Eastman created dry plates for developing photographs, making photography on-the-go much easier ("History of Kodak,”).
Since that time, the Wilkinson Sword-Schick Company has evolved into Gillette’s primary competitor. Through the years, Gillette has strived to stay on the cutting edge of shaving technology in a market that thrives on innovation. This focus led to a game of one-upsmanship with Schick as each company introduced 3-bladed (Gillette’s Mach3), 4-bladed (Schick’s Quattro), and 5-bladed (Gillette’s Fusion) razors in rapid succession. Now, under the ownership and guidance of Procter & Gamble, Gillette faces a saturated U.S. market that fluctuates only when newer, more innovative products are introduced. However, many analysts believe that Gillette and Schick have reached the end of truly meaningful product innovation.